Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-09-10 00:00:00 ET · period of report 2024-09-08 · accession 0001822629-24-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-10 | 2024-09-08 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $60.51 | -3,646 | 373.9K | -1.0% | -$220.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-08 | F | D | 3,646 | $60.51 | 373,859 | D | — | — |